Lunit INSIGHT CXR Triage

K211733

Lunit Inc. · cleared 2021-11-10 · product code QFM · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.3)
Lunit INSIGHT CXR Triage is a radiological computer-assisted triage and notification software that analyzes adult chest X-ray images for the presence of pre-specified suspected critical findings (pleural effusion and/or pneumothorax).
AlgorithmAI-based image analysis algorithms
source quote (p.5)
Lunit INSIGHT CXR Triage is a radiological computer-assisted prioritization software that utilizes AI-based image analysis algorithms to identify pre-specified critical findings (pleural effusion and/or pneumothorax) on frontal chest X-ray images and flag the images in the PACS/workstation to enable prioritized review by the appropriately trained medical specialists who are qualified to interpret chest radiographs.
Adaptive (vs locked)FDA source did not state this
PCCPFDA source did not state this
Cybersecurity addressedFDA source did not state this

Validation studies (2)

Standalone

n=1,385 images

endpoints: ROC AUC; sensitivity; specificity

Retrospective clinical

n=1,708 images

endpoints: ROC AUC; sensitivity; specificity

Reported performance (6 observations)

sensitivity0.8986CI [86.72, 93.00]
source quote (p.7)
sensitivity 89.86% (95% CI: 86.72 - 93.00)
specificity0.9348CI [91.06, 95.91]
source quote (p.7)
specificity 93.48% (95% CI: 91.06 - 95.91)
aurocas written: “auc0.9686CI [0.9547, 0.9824]
source quote (p.7)
ROC AUC 0.9686 (95% CI: 0.9547 - 0.9824)
sensitivityas written: “Sensitivity for pneumothorax0.8892CI [85.60, 92.24]
source quote (p.7)
Sensitivity 88.92% (95% CI: [85.60, 92.24])
specificityas written: “Specificity for pneumothorax0.9051CI [88.18, 92.83]
source quote (p.7)
Specificity 90.51% (95% CI: [88.18, 92.83])
aurocas written: “AUC for pneumothorax0.963CI [0.9521, 0.9739]
source quote (p.7)
ROC AUC 0.9630 (95% CI: 0.9521 - 0.9739)

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
0
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
0
drift signals on this device

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K211733